Erratum

In issue 24, dated 15 June, of Deutsches Ärzteblatt, an editorial error occurred in a reader’s letter that led to the author’s name being incorrect and the affiliation and declaration of competing interests being omitted. Dr rer nat Siegfried Throm responded to the original article entitled “New Drugs: Evidence Relating to Their Therapeutic Value After Introduction to the Market.” He is managing director research, development, innovation at the Verband Forschender Arzneimittelhersteller e.V. (Research-Based Pharmaceutical Companies reg. assoc.).